Announcements Trials

Browse Landscape

Phase

Status

Terminated 5 Completed 4 Active not recruiting 2 Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Carcinoma, Non-Small-Cell Lung 9 Carcinoma, Hepatocellular 9 Esophageal Neoplasms 7 Stomach Neoplasms 4 Small Cell Lung Carcinoma 4 Rectal Neoplasms 4 Nasopharyngeal Carcinoma 4 Colorectal Neoplasms 4 Neoplasms 3 Esophageal Squamous Cell Carcinoma 3 Colonic Neoplasms 3 Urinary Bladder Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Recurrence 2 Hodgkin Disease 2 Glioblastoma 2 mCRPC 1 Uterine Cervical Neoplasms 1 Unresectable Stage III Non-small Cell Lung Cancer 1 Tongue Squamous Cell Carcinoma 1 SCLC, Extensive Stage 1 Rare Tumour 1 Non-Muscle Invasive Bladder Neoplasms 1 Non Squamous Non-small Cell Lung Cancer 1 Neoplasm Metastasis 1 Nasopharyngeal Neoplasms 1 NSCLC 1 MSI-H Colorectal Cancer 1 Lymphoma, Follicular 1 Lymphoma, Extranodal NK-T-Cell 1

Interventions

Cyclophosphamide 4 trastuzumab deruxtecan 3 fludarabine 3 Standard of Care 3 Injections 3 Cisplatin 3 Bevacizumab 3 toripalimab 2 sacituzumab govitecan 2 pembrolizumab 2 fludarabine phosphate 2 Specimen Handling 2 Radiosurgery 2 Pemetrexed 2 Palliative Care 2 Gemcitabine 2 Fulvestrant 2 Fluorouracil 2 Docetaxel 2 130-nm albumin-bound paclitaxel 2 zimberelimab 1 vedolizumab 1 tislelizumab 1 sintilimab 1 lobaplatin 1 lenvatinib 1 ivosidenib 1 irinotecan sucrosofate 1 exemestane 1 eribulin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Neoplasm Metastasis × tislelizumab × Clear all

NCT07348107 2026-01-16

ATARI-PDAC

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase 1 Not yet recruiting

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡